ABK Biomedical Raises $35 Million in Series D Funding Led by J.P. Morgan Life Sciences
ABK Biomedical has raised $35 million in an oversubscribed Series D financing round led by new investor J.P. Morgan Life Sciences Private Capital, announced in a press release. Existing investors including F-Prime, Santé Ventures, Eight Roads Ventures, and an undisclosed medical device company also participated.
The funds will support the company’s ongoing clinical operations, preparation for the commercialization of its Eye90 microspheres, and further product development. Additional capital will be used to expand manufacturing and supply chain capabilities to meet future demand.
Eye90 microspheres, which have received FDA Breakthrough Device Designation, are currently being evaluated in the Route90 FDA IDE pivotal trial. The company aims to use the proceeds to advance the trial and position the product for market readiness.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Sep 29 AIxC Signs $200 Million Term Sheet for Faraday Future Robotics Business Sep 29 Pearson Agrees to Acquire Workera Sep 28 Instinct Raises $1 Billion at $10 Billion Valuation Sep 28 HCLSoftware to Acquire Robotiq.ai for Agentic Automation Sep 28 RiskScout Raises Funding for AI Compliance PlatformMore from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Ayble Health Raises $16 Million for Virtual Digestive Care
NAVER D2SF Backs ImpriMed in $10 Million Bridge Round
Superluminal Medicines Raises $60 Million for Obesity Drug Trial
Kairon Health Raises $5 Million for AI Care Operations Platform
Axya Raises C$17 Million for AI Procurement Platform
Daily AI Brief: the AI news that matters, in your inbox.